News

Incyte’s Jakafi (ruxolitinib) Receives the US FDA’s Approval for the Treatment of Chronic Graft-Versus-Host Disease

Shots: The approval is based on the P-III REACH3 study evaluates the safety & efficacy of Jakafi vs BAT in patients ≥12yrs. with steroid-refractory chronic GVHD after the failure of 1 or 2 lines of systemic therapy The results showed that the patients treated with Jakafi led to significantly improved outcomes across a range of …

Incyte’s Jakafi (ruxolitinib) Receives the US FDA’s Approval for the Treatment of Chronic Graft-Versus-Host Disease Read More »

AstraZeneca makes a big RNA play, teaming up with VaxEquity

AstraZeneca has joined the ranks of big pharma companies bolting on RNA-based technology platforms in the wake of the stellar success of mRNA vaccines for COVID-19. The UK-based drugmaker is making an undisclosed investment in VaxEquity, a spinout from Imperial College London set up last year, whose own RNA-based COVID-19 vaccine was an early contender …

AstraZeneca makes a big RNA play, teaming up with VaxEquity Read More »

Biden under pressure to expand rapid COVID-19 testing

The Biden administration is under pressure to quickly expand rapid coronavirus testing to curb the latest wave of the pandemic.The current system is being strained, and at-home tests are increasingly rare commodities.Manufacturers who cut supply as…

Second hedge fund applies pressure on GSK after taking stake

Activist hedge fund Bluebell Capital Partners has joined Elliott Investment in taking a stake in GlaxoSmithKline and pushing for change at the drugmaker. In a letter to GSK chair Sir Jonathan Symonds, Bluebell has called on GSK to ask its chief executive Emma Walmsley to reapply for her job, and carry out a “thorough and …

Second hedge fund applies pressure on GSK after taking stake Read More »

Virtual engagement and collaborations: the pharmaphorum podcast

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ experience across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals. Joining the pharmaphorum podcast to discuss these changes is Impetus Digital’s co-founder and CEO Natalie Yeadon, in a special episode sponsored …

Virtual engagement and collaborations: the pharmaphorum podcast Read More »

FDA authorizes Pfizer Covid-19 vaccine booster shots, but only for certain groups

The FDA has authorized dosing of booster shots of Pfizer and BioNTech’s Covid-19 vaccine. Consistent with the recommendations of an FDA advisory committee, the agency’s amendment to the emergency authorization covers only certain groups at high risk of infection and complications from the virus.

The Checkup Is in the Mail? Soliciting Letter Carriers to Help Deliver Health Care

Two of America’s toughest problems can be tempered with one solution. The baby boom generation is graying, creating an ever-larger population of older people, many isolated, whose needs the nation is ill equipped to meet or even monitor. Meanwhile, the U.S. Postal Service has gone $160 billion into debt, in part as digital communications have …

The Checkup Is in the Mail? Soliciting Letter Carriers to Help Deliver Health Care Read More »

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?

It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes. And after learning in 2016 that she had Crohn’s disease, a chronic inflammation of the digestive tract, she spent more than four years trying medications before getting her disease under control with …

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch? Read More »

Democrats Roll the Dice on Sweeping Abortion Rights Bill — Again

A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law. “We’ll debate it. …

Democrats Roll the Dice on Sweeping Abortion Rights Bill — Again Read More »

Abbott’s Epic Plus Tissue Valves Receives the US FDA’s Approval for the Treatment of Mitral or Aortic Valve Replacement

Shots: The US FDA has approved Abbott’s Epic Plus & Epic Plus Supra Stented Tissue valves to treat patients with aortic or MV disease who undergoes valve replacement surgery. The devices build off Abbott’s Epic surgical valve platform Abbott’s Epic valve including radiopaque markers helps to improve implantation & allows compatibility for future transcatheter valve …

Abbott’s Epic Plus Tissue Valves Receives the US FDA’s Approval for the Treatment of Mitral or Aortic Valve Replacement Read More »

FDA approves Pfizer COVID booster jabs for higher-risk groups

Just days after its advisory committee meeting voted to approve a third dose of Pfizer and BioNTech’s COVID-19 vaccine, the FDA has followed through and cleared the shot. The FDA has amended the emergency use authorisation (EUA) for Comirnaty in line with its experts’ advice – for people aged over 65 and other adults at …

FDA approves Pfizer COVID booster jabs for higher-risk groups Read More »

5th Antifibrotic Drug Development Summit -AFDD-

The 5th Antifibrotic Drug Development Summit (AFDD) will provide you with a deeper understanding of how to progress early-stage candidates and avoid late-stage failures, know the studies that show early signs of efficacy and surrogate indication opportunities, and evaluate interacting mechanisms for new targets and biomarkers. This unique cross-organ, cross-disease discussion forum will host the transferrable insights …

5th Antifibrotic Drug Development Summit -AFDD- Read More »

Hospital at Home: Aligning Provider Needs with Patient Wishes

Arik Ben Ishay, CEO & Co-Founder of Biobeat 2020 saw three factors combine to define the future of “Hospital at Home” care in a way that will become a new care reality over the coming years. Changing Patient Attitudes Patients became more reluctant and concerned about going to hospitals. The fear of contracting illnesses such …

Hospital at Home: Aligning Provider Needs with Patient Wishes Read More »

Ad agency tries morbid reverse psychology to encourage vaccinations

A truck made its way around Charlotte, North Carolina for several hours on Sunday with an ad on its side declaring “Don’t get vaccinated.” Underneath the message was the name of a funeral home. But it was actually a ploy by an ad…

Get your free flu shot this fall

The Centers for Disease Control and Prevention (CDC) recommends everyone 6 months and older get a yearly flu shot by the end of October. Flu viruses change from year to year, so even if you got the shot before, you should get a vaccine each year to protect against the most common types of viruses.

Google, Microsoft execs: AI should be designed to support, not replace, clinicians

As Google and Microsoft compete over their cloud capabilities for healthcare, both companies are touting tools to make clinicians’ lives easier by streamlining documentation or making records searchable.  At MedCity INVEST Digital Health, executives from both companies agreed on one thing: these tools should play a supporting role for clinicians while keeping patients at the …

Google, Microsoft execs: AI should be designed to support, not replace, clinicians Read More »

Spotting and rooting out bias in AI algorithms for healthcare

Algorithms are everywhere and so are the biases behind them. As algorithms find greater use in healthcare, a panel at MedCity News’ INVEST Digital Health virtual conference addressed how and why algorithms are biased, how that bias affects clinical care, and some possible solutions to bias.

Matternet Launches World’s First City-Wide Medical Drone Network in Abu Dhabi

What You Should Know: – Today, Matternet announced the launch of the world’s first city-wide drone delivery network for the rapid transport of medical goods in Abu Dhabi, in collaboration with the Abu Dhabi Department of Health (DoH) and logistics company Skygo. The network will significantly increase the connectivity of the Emirate’s health ecosystem and …

Matternet Launches World’s First City-Wide Medical Drone Network in Abu Dhabi Read More »

Pearl Health Raises $18M to Support Independent Primary Care Physicians

What You Should Know: – Pearl Health, a New York City-based primary care physicians (PCP) group today announced it has raised $18M in Series A funding led by a16z, with AlleyCorp and Kevin Ryan participating.  – Co-founded by Dr. Jeffrey De Flavio (founder of Groups: Recover Together), Michael Kopko (Oscar Health, Bridgewater Associates) and Ankit …

Pearl Health Raises $18M to Support Independent Primary Care Physicians Read More »

NANI Makes Equity Investment in Strive Health for Risk Payment

What You Should Know: – Strive Health, the national leader in value-based kidney care, and Nephrology Associates of Northern Illinois and Northern Indiana (NANI), the nation’s largest independent nephrology group, today announced a strategic partnership to jointly pursue and manage global risk payment models. – This partnership will benefit people with chronic kidney disease (CKD) …

NANI Makes Equity Investment in Strive Health for Risk Payment Read More »

NOCD Raises $33M for OCD Treatment Platform & Address Global OCD Crisis

What You Should Know:  –NOCD, a Chicago-based provider of obsessive compulsive-disorder (OCD) treatment raises $33M in Series B funding led by F-Prime Capital, with Eight Roads Ventures, and Kaiser Permanente Ventures participating along with existing investors including 7wireVentures, Health Enterprise Partners (HEP), and Chicago Ventures. – The funds will be used to expand NOCD’s community, …

NOCD Raises $33M for OCD Treatment Platform & Address Global OCD Crisis Read More »

West Virginia blames CDC for inflated vaccination figures

West Virginia blamed the Centers for Disease Control and Prevention (CDC) for providing inflated data that caused its vaccination rate to plummet on Wednesday after the error was discovered. The problem was with contractor data…

Researchers detect malaria resistant to key drug in Africa

Researchers in Uganda analyzed blood samples from patients treated with artemesinin, the primary medicine used for malaria in Africa in combination with other drugs. They found that by 2019, nearly 20% of the samples had genetic mutations suggesting the treatment was ineffective.

Will doctors spreading COVID misinformation ever face the music?

A report, based on an analysis of anti-vaccine content on social media platforms, found that 12 people were responsible for 65% of it. The group is composed of physicians, anti-vaccine activists and people known for promoting alternative medicine.

With Demand for Home Care Rising, The Helper Bees Launches ‘Aging-in-Place Provider Marketplace’

The Helper Bees (THB) announced Wednesday the launch of its aging-in-place provider marketplace. Austin, Texas-based THB is a full-service insurtech company that works to create innovative aging-in-place solutions for both payers and consumers. THB’s new marketplace — the next evolution of its “Care Concierge” program — is designed to give individuals in need of home …

With Demand for Home Care Rising, The Helper Bees Launches ‘Aging-in-Place Provider Marketplace’ Read More »

InnovAge CEO Maureen Hewitt: PACE Tailwinds Stronger Than Ever

InnovAge (Nasdaq: INNV) went public earlier this year with a $350 million IPO. It has since set its sights on expansion. The largest Program of All-Inclusive Care for the Elderly (PACE) organization in the country, InnovAge is bullish on its ability to do just that, thanks to both internal confidence and also external, regulatory tailwinds. …

InnovAge CEO Maureen Hewitt: PACE Tailwinds Stronger Than Ever Read More »

Barriers to biosimilar adoption

When typical drugs lose their period of exclusivity, new generic competitors arrive on the market with drastically lower prices. As patients switch from brand to generic drugs, the price of treatments declines. For biologic drugs, biosimilar uptake, however, is significantly less. In part, this is because biosimilars are difficult to manufacture so the price differences …

Barriers to biosimilar adoption Read More »

Future Leader: Sofia Koshevatsky, HealthFlex Home Health & Hospice CEO and Founder

The Future Leaders Awards program is brought to you in partnership with PointClickCare. The program is designed to recognize up-and-coming industry members who are shaping the next decade of senior housing, skilled nursing, home health and hospice care. To see this year’s future leaders, visit https://futureleaders.agingmedia.com/. Sofia Koshevatsky, CEO and founder of Oakland, California-based HealthFlex …

Future Leader: Sofia Koshevatsky, HealthFlex Home Health & Hospice CEO and Founder Read More »

How Seniors Helpers, ComForCare and 24 Hour Home Care Are Building Great Places to Work

At a time when the home care industry is plagued with workforce shortages, Senior Helpers, 24 Hour Home Care and ComForCare have made a name for themselves as best-in-class employers. Among common retention tactics, all three organizations actively elicit feedback by surveying staff on a regular basis. Senior Helpers, 24 Hour Home Care and ComForCare …

How Seniors Helpers, ComForCare and 24 Hour Home Care Are Building Great Places to Work Read More »

A global focus on ending the COVID-19 pandemic

Today, President Biden convened global leaders to confront the challenges around ending this pandemic. We stand with the president, all governments, organizations and sectors in a shared commitment to:

Housing Affordability, Adequacy, and Access to the Internet in Homes of Medicaid Enrollees

The COVID-19 pandemic and the ensuing economic disruption have drawn more attention to longstanding issues related to housing and internet access and how these issues can impact health. As the primary source of health insurance for low-income populations, Medicaid covers a considerable share of people living in homes that are unaffordable, inadequate, or have limited …

Housing Affordability, Adequacy, and Access to the Internet in Homes of Medicaid Enrollees Read More »

Investors see promise in digital health — the challenge is adoption

VCs at MedCity INVEST Digital Health said there’s no shortage of interesting digital health companies, even ones that can prove their innovations are effective. The challenge is winning over insurers and physicians, and finding payment models that work. 

Five reasons tying VA prices to Medicare Part D misses the mark

Some members of Congress are considering a government “negotiation” plan that would tie medicine prices in Medicare to those in the U.S. Department of Veterans Affairs (VA). This misguided approach is just the latest in a series of government price-setting proposals that threaten patients’ access to medicines and future innovation.

Mormon church to mandate masks inside temples

Mormon church leaders on Wednesday announced that masks will be required in its temples, after previously urging followers to wear masks and get vaccinated. The Church of Jesus Christ of Latter-day Saints said the mask mandate would…

Canadian police: Man assaulted nurse for vaccinating his wife

Authorities in Quebec are searching for a man who allegedly punched a nurse for giving his wife a coronavirus vaccine without his consent, Reuters reported. Police spokesman Martin Carrier told the outlet the man approached the nurse Monday…

CMS grants quality reporting exceptions for facilities recovering from Hurricane Ida

The agency has granted certain Medicare quality reporting exceptions to healthcare facilities in areas of Louisiana, Mississippi, New York and New Jersey that were battered by Hurricane Ida. By providing the exceptions, CMS aims to enable facilities to direct their resources toward recovery.

What do frontline caregivers want from digitized healthcare?

Technology has proved to be a blessing for consumers who today have a plethora of care options and improved access to care. This is not the case with frontline providers who continue to suffer from burnout and fatigue. 

WHO scientist: Delta variant is ‘predominant worldwide’

A scientist at the World Health Organization (WHO) said Tuesday that the delta variant of the coronavirus has become “predominant worldwide.”“If delta is identified or starts to circulate in a country where there’s beta, in South Africa for example…

Second hedge fund pushes for change in leadership of GSK

Bluebell Capital takes stake in pharma giant and puts pressure on Emma Walmsley GSK’s chief executive, Emma Walmsley, has come under pressure from a second activist hedge fund, Bluebell Capital Partners, which has taken a stake in the drugmaker to push for change at the top, including forcing her to reapply for her job. The …

Second hedge fund pushes for change in leadership of GSK Read More »

Better late than never? Eczema drug now approved, Incyte says warning unwarranted

Atopic dermatitis patients now have a new option that comes as a topical cream. The FDA approved Incyte’s drug, Opzelura, as a treatment for the inflammatory skin condition, but the regulatory nod comes with a black box warning on the label that broadly covers the entire class of JAK inhibitors.

Research links sexual assault to later brain damage in women

New research set to be published soon by a professor at the University of Pittsburgh’s Graduate School of Public Health found that women who have been sexually assaulted may be at higher risk of developing brain damage connected to dementia and…

Harris unveils $250M commitment to new global health fund

Vice President Harris on Wednesday will call for a new global health security fund at the World Bank to focus on pandemic preparedness, with the Biden administration planning to contribute $250 million in seed funding, a White House official said….

Amnesty says COVID jab producers are causing human rights crisis

Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights and share the technology behind them. The charity says AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax, and Pfizer are fuelling an “unprecedented human rights crisis” as a result and their …

Amnesty says COVID jab producers are causing human rights crisis Read More »

Survey: Nearly 1 in 5 Americans drinking heavily amid pandemic

Nearly one in five Americans say they have been drinking heavily during the pandemic, according to a new survey by The Harris Poll commissioned by biopharmaceutical company Alkermes.The survey defined “heavy drinking” as having two days a week where…

Ascension’s IT arm outsources another 330 jobs

Ascension has completed “the last major step” in a service delivery transition that resulted in workforce reductions, Chief Information Officer Gerry Lewis information wrote in a blog post.

Delta surge appears to be peaking in US: Analysis

The Delta surge appears to be peaking in the United States, meaning a decline in new infections and deaths may be on the way, according to a new analysis.The COVID-19 Scenario Modeling Hub, a group made up of a team of researchers who produce a…

Slow enrollment delays study of Pfizer vaccine in pregnant women

A Pfizer and BioNTech study to determine how the COVID-19 vaccine affects pregnant women has been delayed due to slow enrollment and new vaccination guidelines.”We have stopped enrollment in U.S. because of recommendations…

Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials

Nantes, France, Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, today announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases. Naobios will initiate the GMP …

Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials Read More »

Nomad Health’s Next Move: $63M Raise Takes On-Demand Healthcare Staffing into Workforce Management

By JESSICA DaMASSA, WTF HEALTH Not all who wander are lost: Nomad Health lands a $63M Series D round after a year of 5X revenue growth for their tech-driven healthcare staffing marketplace that helps hospitals hire nurses on-demand. This round, led by Adams Street Partners with participation from all existing investors, brings the company’s total …

Nomad Health’s Next Move: $63M Raise Takes On-Demand Healthcare Staffing into Workforce Management Read More »

Execute healthcare claims editing more accurately—with less provider abrasion

Claim editing is generally a health plan’s first line of defense within its prospective payment integrity (PPI) program. It’s a practice based on following guidelines and rules from organizations like the Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) and codifying them into claim editing rules—so how hard can it …

Execute healthcare claims editing more accurately—with less provider abrasion Read More »

Berkeley opening first RV safe parking program for homeless people

The first RV parking program in Berkeley, Calif. will open at the end of the month in an effort to provide a safe place for homeless residents living in their vehicles. City officials told The San Francisco Chronicle that the site…

How artificial intelligence is making health care more human

Health-care institutions have been anticipating the impact that artificial intelligence (AI) will have on the performance and efficiency of their operations and their workforces—and the quality of patient care.

At an overrun ICU, ‘we are running out of hallways’

What’s different from the early scenes of the pandemic is the public’s response. Not so long ago, the cheers of community support could be heard from the hospital parking lot. Now, tensions are so strained that Billings Clinic is printing signs for its hallways, asking that the staff members not be mistreated.

Sonic hedgehog protein pathway stimulation could help Parkinson’s patients

Levodopa, or L-dopa, is considered the most effective treatment for Parkinson’s disease today. After a few years of treatment, however, almost all patients develop a debilitating side-effect called L-dopa induced dyskinesia, or LID, which causes involuntary movements in the limbs, face, and torso. Deep brain stimulation can alleviate LID, but the procedure is highly invasive …

Sonic hedgehog protein pathway stimulation could help Parkinson’s patients Read More »

Vigeo Reports Completion of VT1021 in P-I/II Study for the Treatment of Recurrent Glioblastoma and Pancreatic Cancer

Shots: The P-I/II dose expansion studies evaluate the safety & preliminary anti-tumor efficacy of VT1021 as monothx. in patients with dose-escalation & expansion cohorts with rGBM & PC. The results of both studies are expected in Q4’21 In the rGBM expansion cohort, the therapy showed a complete tumor regression & PR, patients remain on trial …

Vigeo Reports Completion of VT1021 in P-I/II Study for the Treatment of Recurrent Glioblastoma and Pancreatic Cancer Read More »

Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeholders in a business environment such as companies, investors, and individuals deal with some or other kind of data in their day-to-day life. The data is key to the business prediction that helps to analyze consumer behavior. Companies stores a large amount …

Healthcare Data Breach: What it Means for Companies and the Consumer? Read More »

Average daily COVID-19 deaths highest since early March

The average number of daily COVID-19 deaths in the U.S. has increased to its highest level since early March, as the highly contagious delta variant infects individuals nationwide.The U.S. is seeing an average of more than 1,900 COVID-19…

Takeda Enters into an Exclusive License Agreement with Mirum to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Shots: Takeda will lead the regulatory approval and commercialization of maralixibat in Japan & will also be responsible for the development, including conducting clinical studies in cholestatic indications The collaboration will utilize Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance the product in Japan Mirum has submitted a maralixibat’s NDA to the US …

Takeda Enters into an Exclusive License Agreement with Mirum to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan Read More »

Addressing the HIV epidemic in Eastern Europe and Central Asia

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences. 2021 marks 40 years since the first cases of HIV were reported. In that time, over 79 million people have been diagnosed with HIV, with more than 36 million dying from AIDS-related illnesses, more than any other infectious …

Addressing the HIV epidemic in Eastern Europe and Central Asia Read More »

Boehringer buys Abexxa, bolstering its immuno-oncology pipeline

Boehringer Ingelheim says it has agreed to buy US biotech Abexxa Biologics, its second acquisition in the cancer immunotherapy area in the space of a year. Texas-based Abexxa has been on the Boehringer’s radar since it was set up, as it provided seed funding for the preclinical-stage company in 2016, buying into its approach of …

Boehringer buys Abexxa, bolstering its immuno-oncology pipeline Read More »

Clearsense Acquires Plug-and-Play AI Analytics Firm Compellon

What You Should Know: – Clearsense, an AI-powered data analytics platform company that translates healthcare data into highly consumable insights, today announced the acquisition of Compellon, a privately-held, plug-and-play AI analytics company. – The multi-patented Compellon technology uses AI to re-engineer predictive modeling, removing the technical burden from users. The technology is a hand in …

Clearsense Acquires Plug-and-Play AI Analytics Firm Compellon Read More »

Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty

Six companies warned not to put profit before lives as report shows less than 1% of almost 6bn doses have gone to low-income countries Amnesty International has accused six pharmaceutical companies that have developed Covid-19 vaccines of fuelling a global human rights crisis, citing their refusal to sufficiently waive intellectual property rights, share vaccine technology …

Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty Read More »

Exelixis Presents Results of Cabometyx (cabozantinib) in P-III COSMIC-311 Trial for the Treatment of Radioactive Iodine-Refractory DTC at ESMO 2021

Shots: The P-III COSMIC-311 trial evaluates Cabometyx (60mg, qd) vs PBO in a ratio (2:1) in 258 patients aged ≥12yrs. with previously treated radioactive iodine-refractory DTC across 164 sites globally An updated analysis showed ORR (11% vs 0%) as assessed by BIRC in ITT population including 1 CR, m-OS (19.4mos.) for Cabometyx but not estimable …

Exelixis Presents Results of Cabometyx (cabozantinib) in P-III COSMIC-311 Trial for the Treatment of Radioactive Iodine-Refractory DTC at ESMO 2021 Read More »

2nd Applied Biocatalysis Summit 2021

Advancing Sustainable, Streamlined Small Molecules, API and Fine Chemical Production using Enzyme Engineering & Scalable Industrial Biotransformations Attending the 2nd Applied Biocatalysis Summit is the perfect opportunity to understand the most recent developments in enzyme-catalyzed processes, computational technologies, and cutting-edge methodologies in biocatalytic cascade reactions to help the API and chemical industries apply biocatalysis more …

2nd Applied Biocatalysis Summit 2021 Read More »

US to purchase 500M more vaccine doses for world

President Biden will announce Wednesday that the United States is purchasing an additional 500 million doses of Pfizer’s COVID-19 vaccine to donate to the world, as he seeks to boost the global vaccination effort.The announcement comes as part of a…

Cyberattacks can extend length of stay, delay procedures, survey says

Fifty-six percent of IT and security professionals said cyberattacks have affected patient care, according to a new survey from Ponemon Institute. Nearly one-quarter of those respondents said such attacks resulted in an increased mortality rate, among other consequences.

Study finds 10% of medicines in England are overprescribed

An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review. The study, led by the Chief Pharmaceutical Officer for England Dr Keith Ridge, estimates that 10% of items dispensed in primary care are inappropriate or could be better served with alternative treatments. …

Study finds 10% of medicines in England are overprescribed Read More »

Incyte leads JAK push into eczema as FDA clears Opzelura cream

The FDA has approved Incyte’s Opzelura cream for atopic dermatitis, commonly called eczema, becoming the first and only topical JAK inhibitor registered in the US. Opzelura (ruxolitinib) – which has been cleared to treat atopic dermatitis in adolescents and adults whose symptoms cannot be treated using other topical therapies – has beaten its orally-administered rivals …

Incyte leads JAK push into eczema as FDA clears Opzelura cream Read More »

At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’

BILLINGS, Mont. — Nurses fill the hospital room to turn a patient from his stomach to his back. The ventilator forcing air into him is most effective when he’s on his stomach, so he is in that position most hours of the day, sedated and paralyzed by drugs. Lying on his stomach all those hours …

At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’ Read More »

Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief

President Joe Biden’s failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it’s baffling for the agency to be without a permanent leader during a national health crisis. The pandemic has taxed the FDA, an 18,000-person agency whose chiefs …

Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief Read More »

Will ‘Dr. Disinformation’ Ever Face the Music?

Earlier this month, Dr. Rashid Buttar posted on Twitter that covid-19 “was a planned operation” and shared an article alleging that most people who got the covid vaccine would be dead by 2025. His statement is a recent example in what has been a steady stream of spurious claims surrounding the covid vaccines and treatments …

Will ‘Dr. Disinformation’ Ever Face the Music? Read More »

Home Births Gain Popularity in ‘Baby Bust’ Decade

In a back-to-the-future twist on birth trends, California is seeing a sustained rise in the number of women choosing to deliver their babies in settings other than a hospital, a shift that accelerated as the pandemic created more risky and onerous conditions in many hospitals. About 5,600 people gave birth outside a hospital in California …

Home Births Gain Popularity in ‘Baby Bust’ Decade Read More »

Serum Institute to invest $68 million in UK vaccine maker Oxford Biomedica

Serum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, spun off from Oxford University in 1995, said it would use the funds to develop the fallow area at its Oxbox plant into a manufacturing space expected to come online …

Serum Institute to invest $68 million in UK vaccine maker Oxford Biomedica Read More »

Seagen and Genmab’s Tivdak (tisotumab vedotin-tftv) Receive the US FDA’s Accelerated Approval for the Treatment of Recurrent or Metastatic Cervical Cancer

Shots: The approval is based on the P-II innovaTV 204 clinical trials evaluating tisotumab vedotin in 101 patients with r/mCC who had received no more than two prior systemic regimens in the recurrent or metastatic setting, including one prior Pt-based CT regimen The results showed an ORR (24%) as assessed by IRC using RECIST v1.1 …

Seagen and Genmab’s Tivdak (tisotumab vedotin-tftv) Receive the US FDA’s Accelerated Approval for the Treatment of Recurrent or Metastatic Cervical Cancer Read More »

FDA clears AI-powered prostate cancer detection software

Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA. The software – called Paige Prostate – is the first artificial intelligence-based to be approved by the FDA for this purpose, according to the US regulator. It is used to screen for signs of cancer …

FDA clears AI-powered prostate cancer detection software Read More »

Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research

Shots: The acquisition includes upfront, milestones, and other consideration payments. Abexxa will continue to operate in the Arlington The acquisition will allow Boehringer to access Abexxa’s expertise and capabilities in targeting cancer-specific proteins by using its technology to develop cancer immunotherapies and Abs for solid cancers The acquisition also bolsters Boehringer’s commitment to identifying the …

Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research Read More »

Incyte’s Opzelura (ruxolitinib) Receives the US FDA’s Approval for the Treatment of Atopic Dermatitis

Shots: The approval is based on the TRuE-AD clinical trial program which consists of two P-III studies i.e., TRuE-AD1 & 2 evaluating the safety and efficacy of Opzelura cream (1.5%, bid) vs vehicle (non-medicated cream) in 1200+ adolescents & adults aged ≥12yrs. with mild to moderate AD The results showed that the patients achieved IGA-TS …

Incyte’s Opzelura (ruxolitinib) Receives the US FDA’s Approval for the Treatment of Atopic Dermatitis Read More »

4 Best Practices to Deliver Virtual Palliative Care for Providers

Michael Fratkin, MD, FAAHPM, Chief Medical Officer at Vynca More and more people are living with serious illnesses such as cancer, heart failure, chronic obstructive pulmonary disease and liver disease. The National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) reports that 60 percent of U.S. adults have a chronic disease, which is the …

4 Best Practices to Deliver Virtual Palliative Care for Providers Read More »

Healthcare leaders share lessons learned addressing social determinants of health

Leaders with insurers and health systems said that taking a holistic approach and partnering with community organizations is key to standing up a successful social determinants of health program at a panel discussion hosted by MedCity INVEST Digital Health. 

Biden launches investigation into Texas school mask mandate ban

The Biden administration has launched a civil rights investigation into Texas Gov. Greg Abbott’s (R) executive order prohibiting school mask mandates, the latest in a series of probes by the Department of Education into whether the statewide bans…

MetroHealth names leaders for equity initiatives

Alan Nevel, who has served as MetroHealth’s chief diversity and human resources officer since 2018, will become its first chief equity officer. Dr. Charles Modlin has been named MetroHealth’s first medical director of inclusion, diversity and equity.

Researchers use exosome-based strategy to block HIV in mice

Researchers used exosomes, tiny nanoparticles capable of being taken up by cells, to deliver novel protein into the cells of mice infected with HIV. The protein attached to HIVs’ genetic material and prevented it from replicating, resulting in reduced levels of HIV in the bone marrow, spleen, and brain. The study paves the way for …

Researchers use exosome-based strategy to block HIV in mice Read More »

Walgreens Boots Alliance Invests $970B in Shields to ‘Further Expand Its Health Care Reach in Communities’

Walgreens Boots Alliance (Nasdaq: WBA) plans to invest $970 million in Shields Health Solutions, which aids both hospitals and health systems with specialty pharmacy services. It’s another major move for Walgreens, which is trying to position itself as an all-encompassing health care behemoth prepared for the sector’s near- and long-term trends. The deal, which is …

Walgreens Boots Alliance Invests $970B in Shields to ‘Further Expand Its Health Care Reach in Communities’ Read More »

Papa Partners with Milliman’s HealthIO to Create More Touch Points in the Home for Seniors

The senior companionship company Papa has made another partnership that will accelerate its impact on seniors aging in place across the country. Milliman Inc. — a global consulting and actuarial firm — and Papa are teaming up to provide hands-on help to Milliman’s HealthIO program members. HealthIO is a mobile platform that helps seniors with …

Papa Partners with Milliman’s HealthIO to Create More Touch Points in the Home for Seniors Read More »

Right at Home CEO Brian Petranick: Strategic Buyers Will Drive Future Home Care M&A Activity

Since last spring, home care companies have had to battle through an ongoing pandemic and a worsening labor crisis. They’ve had to face those challenges, too, while trying to meet the needs of a rapidly growing U.S. senior population. In many ways, it has felt like trying to stay afloat in an endless wave pool, …

Right at Home CEO Brian Petranick: Strategic Buyers Will Drive Future Home Care M&A Activity Read More »

Unite Us acquires NowPow to bulk up SDOH screenings, referrals platform

Unite Us will integrate NowPow’s tools and community partners into its closed-loop referral system, which can be used to screen for social factors that negatively affect health, like food or housing insecurity, and then electronically refer patients to resources in their community.

Gary Kaplan says honesty can improve healthcare

After more than 20 years as CEO of one of the most well-known systems for quality and safety, Gary Kaplan is leaving Virginia Mason Franciscan Health to spearhead efforts at parent company CommonSpirit Health.

Gary Kaplan leaving Virginia Mason post

Gary Kaplan is stepping down from his role as CEO at Virginia Mason Franciscan Health as of Jan. 2022, but will continue advising the new sole CEO Ketul Patel.

Unite Us Acquires NowPow’s Personalized Community Referral Platform

What You Should Know: – Unite Us, a New York City-based technology company connecting health and social care services, today announced the acquisition of NowPow, the Chicago-based referral platform grounded in science and community. – This combination will create the nation’s leading integrated health and social care network connecting people to the resources they need …

Unite Us Acquires NowPow’s Personalized Community Referral Platform Read More »

Novel method of bioprinting neuron cells

Researchers have developed a new method of bioprinting adult neuron cells. They’re using a new laser-assisted technology that maintains high levels of cell viability and functionality.

Pager Secures $70M to Expand Virtual Care Navigation & Journey Platform

What You Should Know: – Pager, a New York City-based virtual care navigation and collaboration platform, today announced it has raised $70 million as part of an equity and debt financing round led by Susquehanna Private Equity Investments and included new and existing financial and strategic investors, including an affiliate of Horizon Healthcare Services, Inc., …

Pager Secures $70M to Expand Virtual Care Navigation & Journey Platform Read More »

Xealth Secures $24M to Scale Digital Prescription Platform

What You Should Know: – Xealth, a Seattle-based provider enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health. Seven additional health systems – Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and …

Xealth Secures $24M to Scale Digital Prescription Platform Read More »

eVisit Nabs $45 Million to Scale Virtual Care Platform

What You Should Know: – eVisit, a Phoenix-based virtual care platform for large healthcare providers, today announced that it has closed a $45M in Series B financing round led by the Growth Equity business within Goldman Sachs Asset Management (Goldman Sachs), with participation from Texas Health Resources, Tom Burton and Steve Barlow (Co-founders of Health …

eVisit Nabs $45 Million to Scale Virtual Care Platform Read More »

Alpha Medical Lands $24M for Women’s Virtual Primary Care Platform

What You Should Know: – Femtech company Alpha Medical, today announced it has raised $24M in Series B funding to expand its market share in women’s virtual primary care. Alpha Medical recognizes that women’s healthcare needs reshaping to include reproductive health, primary and urgent care, and mental health services. – Alpha Medical leverages a unique …

Alpha Medical Lands $24M for Women’s Virtual Primary Care Platform Read More »

Nomad Health Secures $63M for Digital Marketplace for Temp Healthcare Jobs

What You Should Know: – Nomad Health, a digital marketplace for temporary healthcare jobs, today announced the completion of $63M in new equity and debt financing led by Adams Street Partners and all existing investors participated, including Icon Ventures, Polaris Partners, RRE Ventures, .406 Ventures, First Round Capital, and Silicon Valley Bank. With this financing, …

Nomad Health Secures $63M for Digital Marketplace for Temp Healthcare Jobs Read More »

Eric Trump to speak at conference led by prominent anti-vaxxers

Eric Trump will be a keynote speaker next month at a conference organized by a couple who have called the COVID-19 vaccine “abominable” and a “COVID kill shot,” The Daily Beast reported. “I am not there to talk about vaccines,” the…